|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/10 | (2006.01) |
| A61P 25/28 | (2018.01) | ||
| A61K 31/275 | (2006.01) | ||
| A61K 31/275 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/0053 | (2013.01) | ||
| A61K 9/008 | (2013.01) |
| (11) | Number of the document | 3746057 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19746676.6 |
| Date of filing the European patent application | 2019-01-31 | |
| (97) | Date of publication of the European application | 2020-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/016012 |
| Date | 2019-01-31 |
| (87) | Number | WO 2019/152627 |
| Date | 2019-08-08 |
| (30) | Number | Date | Country code |
| 201862624637 P | 2018-01-31 | US |
| (72) |
DINARELLO, Charles A. , US
|
| (73) |
Olatec Therapeutics, Inc. ,
800 Fifth Avenue, 25 Floor, New York, NY 10065,
US
|
| (54) | DAPANSUTRILE FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE |
| DAPANSUTRILE FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE |